首页 > 最新文献

Current Urology Reports最新文献

英文 中文
Innate Versus Acquired: A Review of Predictive Technical Aptitude Assessments in Surgical Trainee Selection. 先天与后天:外科培训生选择的预测性技术能力评估综述。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-01-14 DOI: 10.1007/s11934-024-01253-1
Harrison M Drebin, Zoë C Cohen, Christopher B Anderson, Gina M Badalato

Purpose of review: The evaluation and selection process of similarly qualified applicants for surgical residency positions in the United States (US) is challenging. Technical aptitude assessments may provide an opportunity to improve the selection process by offering insight into a candidate's technical skills. The use of these assessments prompts consideration of the degree to which technical aptitude in surgery is innate versus acquired. In this narrative review, we review the state of these assessments and the limitations of developing and validating these instruments.

Recent findings: Recent evidence suggests that technical aptitude can be quantified in medical students prior to selection for surgical training; however, both technical aptitude and dedicated practice of technical skills influence operative performance. In the US, technical aptitude assessments are inconsistently used in selecting candidates for surgical residency. Internationally, few countries have implemented standardized technical aptitude assessments in their surgical trainee selection processes. The development of technical aptitude assessments is ongoing worldwide. Technical aptitude assessments may help identify individuals particularly well-suited for a surgical career or those who might benefit from additional practice or remediation. The potential role of technical aptitude assessments in the selection process for surgical trainees remains uncertain. Consideration of these instruments requires an understanding of meaningful outcomes associated with particular technical assessments as well as the assessments' limitations.

审查的目的:评估和选择过程同样合格的申请人外科住院医师职位在美国(美国)是具有挑战性的。技术能力评估可以提供一个机会,通过深入了解候选人的技术技能来改进选择过程。这些评估的使用促使人们考虑外科技术能力是先天还是后天的程度。在这篇叙述性的综述中,我们回顾了这些评估的现状以及开发和验证这些工具的局限性。最近的发现:最近的证据表明,在选择外科训练之前,医学生的技术能力可以量化;然而,技术能力和技术技能的专门实践都会影响操作绩效。在美国,技术能力评估在选择外科住院医师候选人时并不一致。在国际上,很少有国家在其外科培训生选择过程中实施标准化的技术能力评估。技术能力评估的发展正在世界范围内进行。技术能力评估可以帮助识别特别适合外科职业的个体,或者那些可能从额外的实践或补救中受益的个体。技术能力评估在外科受训者选择过程中的潜在作用仍然不确定。考虑这些文书需要了解与特定技术评估相关的有意义的结果以及评估的局限性。
{"title":"Innate Versus Acquired: A Review of Predictive Technical Aptitude Assessments in Surgical Trainee Selection.","authors":"Harrison M Drebin, Zoë C Cohen, Christopher B Anderson, Gina M Badalato","doi":"10.1007/s11934-024-01253-1","DOIUrl":"https://doi.org/10.1007/s11934-024-01253-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>The evaluation and selection process of similarly qualified applicants for surgical residency positions in the United States (US) is challenging. Technical aptitude assessments may provide an opportunity to improve the selection process by offering insight into a candidate's technical skills. The use of these assessments prompts consideration of the degree to which technical aptitude in surgery is innate versus acquired. In this narrative review, we review the state of these assessments and the limitations of developing and validating these instruments.</p><p><strong>Recent findings: </strong>Recent evidence suggests that technical aptitude can be quantified in medical students prior to selection for surgical training; however, both technical aptitude and dedicated practice of technical skills influence operative performance. In the US, technical aptitude assessments are inconsistently used in selecting candidates for surgical residency. Internationally, few countries have implemented standardized technical aptitude assessments in their surgical trainee selection processes. The development of technical aptitude assessments is ongoing worldwide. Technical aptitude assessments may help identify individuals particularly well-suited for a surgical career or those who might benefit from additional practice or remediation. The potential role of technical aptitude assessments in the selection process for surgical trainees remains uncertain. Consideration of these instruments requires an understanding of meaningful outcomes associated with particular technical assessments as well as the assessments' limitations.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"25"},"PeriodicalIF":2.5,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142982617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder Cancer. 非肌性浸润性膀胱癌治疗期间下尿路症状的处理。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-01-06 DOI: 10.1007/s11934-024-01250-4
Benjamin Seiden, Divya Ajay, Felix Cheung, Matthew Clements, Eugene Pietzak

Purpose of review: This narrative review aims to report upon the existing treatment evidence and strategies for managing lower urinary tract symptoms (LUTS) during treatment, including transurethral resection and intravesical therapy. This review also attempts to examine novel approaches to mitigate treatment-related lower urinary tract symptoms and improve treatment adherence.

Recent findings: There is sparse but promising evidence in improving LUTS secondary to intravesical therapy. Oral agents including phenazopyridine and hyaluronic acid, Bacillus Calmette-Guerin dose reduction, and emerging therapies including beta-3 agonists as well as Onabotulinumtoxin A injections all have demonstrated encouraging improvement in LUTS in limited research. Although recent literature explores new medications and potential strategies for managing intravesical therapy-related LUTS, further research is required to establish efficacy and new consensus on treatment strategies. Further research is also required to establish effective LUTS mitigation strategies with other emerging intravesical therapy regimens.

综述目的:本综述旨在报道治疗过程中处理下尿路症状(LUTS)的现有治疗证据和策略,包括经尿道切除术和膀胱内治疗。本综述还试图探讨减轻治疗相关下尿路症状和提高治疗依从性的新方法。最近的发现:在改善膀胱内治疗继发的LUTS方面,有很少但有希望的证据。在有限的研究中,口服药物包括非那吡啶和透明质酸,卡介苗- guerin剂量减少,以及新兴疗法包括β -3激动剂和onabotulintoxin A注射都显示出令人鼓舞的LUTS改善。虽然最近的文献探讨了治疗膀胱内治疗相关LUTS的新药物和潜在策略,但需要进一步的研究来确定疗效和治疗策略的新共识。还需要进一步的研究,以建立有效的LUTS缓解策略与其他新兴的膀胱内治疗方案。
{"title":"Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder Cancer.","authors":"Benjamin Seiden, Divya Ajay, Felix Cheung, Matthew Clements, Eugene Pietzak","doi":"10.1007/s11934-024-01250-4","DOIUrl":"https://doi.org/10.1007/s11934-024-01250-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>This narrative review aims to report upon the existing treatment evidence and strategies for managing lower urinary tract symptoms (LUTS) during treatment, including transurethral resection and intravesical therapy. This review also attempts to examine novel approaches to mitigate treatment-related lower urinary tract symptoms and improve treatment adherence.</p><p><strong>Recent findings: </strong>There is sparse but promising evidence in improving LUTS secondary to intravesical therapy. Oral agents including phenazopyridine and hyaluronic acid, Bacillus Calmette-Guerin dose reduction, and emerging therapies including beta-3 agonists as well as Onabotulinumtoxin A injections all have demonstrated encouraging improvement in LUTS in limited research. Although recent literature explores new medications and potential strategies for managing intravesical therapy-related LUTS, further research is required to establish efficacy and new consensus on treatment strategies. Further research is also required to establish effective LUTS mitigation strategies with other emerging intravesical therapy regimens.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"24"},"PeriodicalIF":2.5,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence (AI) and Men's Health Clinic Efficiency and Clinic Billing. 人工智能(AI)与男性健康诊所效率和诊所计费。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-12-27 DOI: 10.1007/s11934-024-01252-2
Nickolas Kinachtchouk, David Canes

Purpose of review: Artificial Intelligence (AI) has produced a significant impact across various industries, including healthcare. In the outpatient clinic setting, AI offers promising improvements in efficiency through Chatbots, streamlined medical documentation, and personalized patient education materials. On the billing side, AI technologies hold potential for optimizing the selection of appropriate billing codes, automating prior authorizations, and enhancing healthcare fraud detection. The purpose of this review is to explore the current applications of AI in men's health clinics, with a focus on enhancing clinic efficiency and billing practices.

Recent findings: Current uses of AI, including AI-powered Chatbots, Large Language Models (LLM) and Natural Language Processing (NLP), are discussed with a focus on their application in men's health clinics. Additionally, the challenges associated with their implementation are highlighted.

审查目的:人工智能(AI)对包括医疗保健在内的各个行业产生了重大影响。在门诊环境中,人工智能通过聊天机器人、简化的医疗文档和个性化的患者教育材料,提高了效率。在计费方面,人工智能技术在优化适当计费代码的选择、自动化事先授权和增强医疗保健欺诈检测方面具有潜力。本综述旨在探讨人工智能在男性健康诊所的应用现状,重点是提高诊所效率和计费实践。最近的发现:讨论了人工智能的当前应用,包括人工智能聊天机器人、大型语言模型(LLM)和自然语言处理(NLP),重点讨论了它们在男性健康诊所的应用。此外,还强调了与实施相关的挑战。
{"title":"Artificial Intelligence (AI) and Men's Health Clinic Efficiency and Clinic Billing.","authors":"Nickolas Kinachtchouk, David Canes","doi":"10.1007/s11934-024-01252-2","DOIUrl":"10.1007/s11934-024-01252-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>Artificial Intelligence (AI) has produced a significant impact across various industries, including healthcare. In the outpatient clinic setting, AI offers promising improvements in efficiency through Chatbots, streamlined medical documentation, and personalized patient education materials. On the billing side, AI technologies hold potential for optimizing the selection of appropriate billing codes, automating prior authorizations, and enhancing healthcare fraud detection. The purpose of this review is to explore the current applications of AI in men's health clinics, with a focus on enhancing clinic efficiency and billing practices.</p><p><strong>Recent findings: </strong>Current uses of AI, including AI-powered Chatbots, Large Language Models (LLM) and Natural Language Processing (NLP), are discussed with a focus on their application in men's health clinics. Additionally, the challenges associated with their implementation are highlighted.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"23"},"PeriodicalIF":2.5,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence-Based Clinical Decision-Making in Erectile Dysfunction: a Narrative Review. 基于人工智能的临床决策在勃起功能障碍:叙述回顾。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-12-11 DOI: 10.1007/s11934-024-01251-3
Ahmet Serdar Teoman, Ege Can Serefoglu

Purpose of review: Artificial Intelligence (AI) has great potential in erectile dysfunction (ED) diagnosis and treatment. This review aims to summarize AI-based clinical decision-making in ED.

Recent findings: Based on the literature search, forty-seven articles related to AI and ED were analyzed and their findings were summarized. AI may help diagnose ED and offer treatment for it. Developing AI chatbots may also be beneficial for ED patients who are embarrassed to seek treatment. However, there are deficiencies in AI programs and a lack of accuracy in offering precise diagnoses and treatments for ED. AI technology integrates positively into ED clinical decision-making processes and needs progressive research to gain precision and efficiency.

综述目的:人工智能(AI)在勃起功能障碍(ED)的诊断和治疗方面具有巨大的潜力。本文综述了基于人工智能的ED临床决策。最近的研究发现:在文献检索的基础上,分析了47篇与人工智能和ED相关的文章,并对其研究结果进行了总结。人工智能可以帮助诊断ED并提供治疗。开发人工智能聊天机器人也可能对那些不好意思寻求治疗的ED患者有益。然而,人工智能在为ED提供精确的诊断和治疗方面存在不足,缺乏准确性。人工智能技术积极融入ED临床决策过程,需要不断研究以获得精度和效率。
{"title":"Artificial Intelligence-Based Clinical Decision-Making in Erectile Dysfunction: a Narrative Review.","authors":"Ahmet Serdar Teoman, Ege Can Serefoglu","doi":"10.1007/s11934-024-01251-3","DOIUrl":"https://doi.org/10.1007/s11934-024-01251-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>Artificial Intelligence (AI) has great potential in erectile dysfunction (ED) diagnosis and treatment. This review aims to summarize AI-based clinical decision-making in ED.</p><p><strong>Recent findings: </strong>Based on the literature search, forty-seven articles related to AI and ED were analyzed and their findings were summarized. AI may help diagnose ED and offer treatment for it. Developing AI chatbots may also be beneficial for ED patients who are embarrassed to seek treatment. However, there are deficiencies in AI programs and a lack of accuracy in offering precise diagnoses and treatments for ED. AI technology integrates positively into ED clinical decision-making processes and needs progressive research to gain precision and efficiency.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"22"},"PeriodicalIF":2.5,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-Related Quality of Life Across the Spectrum of Bladder Cancer: A Current Review. 膀胱癌患者与健康相关的生活质量:最新综述
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-12-11 DOI: 10.1007/s11934-024-01248-y
Kate A Moody, Samuel S Iofel, Matthew B Clements

Purpose of review: The purpose of this review is to highlight the health-related quality of life (HRQOL) burden of bladder cancer due to the disease itself and its treatments.

Recent findings: Large database studies have provided evidence that patients with bladder cancer have worse HRQOL than the general population. While transurethral resections and intravesical therapy are known to cause urinary symptoms, a large impact on HRQOL otherwise has not been demonstrated. Radical cystectomy (RC) has considerable morbidity, but after an initial adjustment period, there are favorable HRQOL outcomes. Evidence is insufficient to conclude that there are HRQOL advantages for continent versus ileal conduit urinary diversion, minimally invasive RC, or trimodal therapy. Bladder cancer and its treatment has a considerable HRQOL burden, but even among those requiring radical treatment, acceptable long term HRQOL is possible. Research on improved HRQOL assessment and translating this to personalized support are needed.

综述目的:本综述的目的是强调膀胱癌本身及其治疗对健康相关生活质量(HRQOL)的影响。最近的发现:大型数据库研究提供的证据表明,膀胱癌患者的HRQOL比一般人群差。虽然经尿道切除术和膀胱内治疗已知会引起泌尿系统症状,但尚未证明对HRQOL有很大影响。根治性膀胱切除术(RC)有相当高的发病率,但经过初始适应期后,HRQOL结果良好。目前还没有足够的证据表明,陆地与回肠尿管转移、微创RC或三联疗法在HRQOL方面有优势。膀胱癌及其治疗有相当大的HRQOL负担,但即使在需要根治性治疗的患者中,可接受的长期HRQOL也是可能的。需要研究改进的HRQOL评估并将其转化为个性化的支持。
{"title":"Health-Related Quality of Life Across the Spectrum of Bladder Cancer: A Current Review.","authors":"Kate A Moody, Samuel S Iofel, Matthew B Clements","doi":"10.1007/s11934-024-01248-y","DOIUrl":"10.1007/s11934-024-01248-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to highlight the health-related quality of life (HRQOL) burden of bladder cancer due to the disease itself and its treatments.</p><p><strong>Recent findings: </strong>Large database studies have provided evidence that patients with bladder cancer have worse HRQOL than the general population. While transurethral resections and intravesical therapy are known to cause urinary symptoms, a large impact on HRQOL otherwise has not been demonstrated. Radical cystectomy (RC) has considerable morbidity, but after an initial adjustment period, there are favorable HRQOL outcomes. Evidence is insufficient to conclude that there are HRQOL advantages for continent versus ileal conduit urinary diversion, minimally invasive RC, or trimodal therapy. Bladder cancer and its treatment has a considerable HRQOL burden, but even among those requiring radical treatment, acceptable long term HRQOL is possible. Research on improved HRQOL assessment and translating this to personalized support are needed.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"21"},"PeriodicalIF":2.5,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142806464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Third-Line Therapeutic Interventions for Non-Neurogenic Bladder Dysfunction in Children. 儿童非神经源性膀胱功能障碍的三线治疗干预。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-02 DOI: 10.1007/s11934-024-01227-3
Alyssa M Lombardo, Seth A Alpert

Purpose of review: The aim of this article is to review considerations and efficacy of third-line treatments for pediatric non-neurogenic bladder dysfunction, including Botulinum toxin A (BoTNA), Posterior Tibial Nerve Stimulation (PTNS), and Sacral Neuromodulation (SNM).

Recent findings: Federal Drug Administration approval for use of beta-3-agonists in overactive detrusor activity in pediatric patients may provide an additional step prior to third-line therapies. New long-term data on pediatric SNM efficacy, complications, and revision rates will provide valuable information for counseling families. BoTNA offers a safe and efficacious treatment to decrease detrusor contractility and improve bladder capacity but is limited by the half-life of BoNTA agent. Percutaneous or transcutaneous PTNS offers improved voided volumes or cure in some patients but is time-intensive. SNM can be utilized in a variety of LUTD pathology with high success rate and cure but should consider cumulative anesthetic and fluoroscopic exposures for battery replacements and re-positioning for patient growth.

综述目的:本文旨在综述治疗小儿非神经源性膀胱功能障碍的三线疗法的注意事项和疗效,包括 A 型肉毒杆菌毒素 (BoTNA)、胫后神经刺激 (PTNS) 和骶神经调控 (SNM):最近的研究结果:美国联邦药品管理局批准使用β-3-激动剂治疗儿童患者的过度逼尿肌活动,这为三线疗法提供了一个新的步骤。关于小儿SNM疗效、并发症和翻修率的新的长期数据将为咨询家庭提供有价值的信息。BoTNA 是一种安全有效的治疗方法,可降低逼尿肌收缩力并改善膀胱容量,但受 BoNTA 制剂半衰期的限制。经皮或经皮 PTNS 可改善部分患者的排尿量或治愈,但耗时较长。SNM可用于各种LUTD病理,成功率和治愈率都很高,但应考虑到更换电池和重新定位以适应患者生长所需的累积麻醉和透视暴露。
{"title":"Third-Line Therapeutic Interventions for Non-Neurogenic Bladder Dysfunction in Children.","authors":"Alyssa M Lombardo, Seth A Alpert","doi":"10.1007/s11934-024-01227-3","DOIUrl":"10.1007/s11934-024-01227-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>The aim of this article is to review considerations and efficacy of third-line treatments for pediatric non-neurogenic bladder dysfunction, including Botulinum toxin A (BoTNA), Posterior Tibial Nerve Stimulation (PTNS), and Sacral Neuromodulation (SNM).</p><p><strong>Recent findings: </strong>Federal Drug Administration approval for use of beta-3-agonists in overactive detrusor activity in pediatric patients may provide an additional step prior to third-line therapies. New long-term data on pediatric SNM efficacy, complications, and revision rates will provide valuable information for counseling families. BoTNA offers a safe and efficacious treatment to decrease detrusor contractility and improve bladder capacity but is limited by the half-life of BoNTA agent. Percutaneous or transcutaneous PTNS offers improved voided volumes or cure in some patients but is time-intensive. SNM can be utilized in a variety of LUTD pathology with high success rate and cure but should consider cumulative anesthetic and fluoroscopic exposures for battery replacements and re-positioning for patient growth.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"331-338"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141874442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of Radical Nephrectomy and Inferior Vena Cava Thrombectomy. 根治性肾切除术和下腔静脉血栓形成术的结果。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-12-01 Epub Date: 2024-08-14 DOI: 10.1007/s11934-024-01228-2
Roberto Filizzola, Daniel Romero, Samuel Mendez, David Brunstein, Alejandro Benitez

Purpose of review: Renal Cell Carcinoma (RCC) with invasion into the inferior vena cava (IVC) is a rare and mortal condition. Patients with RCC have an average life expectancy of no more than six months, thus requiring an aggressive surgical approach. We analyze the outcomes of patients that underwent surgery at a single medical institution.

Recent findings: The analysis of recent series of successful treatment with radical nephrectomy and IVC thrombectomy shows a 5 year survival from 45 to 69%. We found in the analyzed series that the success of the treatment in these patients depends on the resection of the renal tumor and venous thrombectomy. We found that at our medical institution nephrectomy and IVC thrombectomy with primary repair have no intraoperative mortality and no pulmonary embolism. Nephrectomy and thrombectomy of IVC is a reliable approach for patients with advance RCC.

综述目的:侵犯下腔静脉(IVC)的肾细胞癌(RCC)是一种罕见的致命疾病。RCC 患者的平均预期寿命不超过 6 个月,因此需要积极的手术治疗。我们分析了在一家医疗机构接受手术的患者的治疗效果:对近期成功接受根治性肾切除术和输尿管血栓切除术治疗的系列患者进行的分析表明,患者的 5 年生存率在 45% 到 69% 之间。我们在分析的系列研究中发现,这些患者的治疗成功与否取决于肾肿瘤切除术和静脉血栓切除术。我们发现,在我们的医疗机构中,肾切除术和静脉血栓切除术加初级修复术没有术中死亡率,也没有肺栓塞。肾切除术和 IVC 血栓切除术是治疗晚期 RCC 患者的可靠方法。
{"title":"Results of Radical Nephrectomy and Inferior Vena Cava Thrombectomy.","authors":"Roberto Filizzola, Daniel Romero, Samuel Mendez, David Brunstein, Alejandro Benitez","doi":"10.1007/s11934-024-01228-2","DOIUrl":"10.1007/s11934-024-01228-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>Renal Cell Carcinoma (RCC) with invasion into the inferior vena cava (IVC) is a rare and mortal condition. Patients with RCC have an average life expectancy of no more than six months, thus requiring an aggressive surgical approach. We analyze the outcomes of patients that underwent surgery at a single medical institution.</p><p><strong>Recent findings: </strong>The analysis of recent series of successful treatment with radical nephrectomy and IVC thrombectomy shows a 5 year survival from 45 to 69%. We found in the analyzed series that the success of the treatment in these patients depends on the resection of the renal tumor and venous thrombectomy. We found that at our medical institution nephrectomy and IVC thrombectomy with primary repair have no intraoperative mortality and no pulmonary embolism. Nephrectomy and thrombectomy of IVC is a reliable approach for patients with advance RCC.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"339-342"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Professional Burnout and Career Choice Regret in Urology Residents. 泌尿科住院医生的职业倦怠和职业选择后悔。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-17 DOI: 10.1007/s11934-024-01226-4
Kevin F Hanna, Kevin Koo

Purpose of review: High rates of professional burnout and career choice regret among urology residents may increase professional dissatisfaction, shorten career longevity, and exacerbate urology workforce shortages. Understanding the prevalence of and risk factors for burnout may help develop interventions.

Recent findings: Up to 48% of contemporary U.S. urology residents experience burnout symptoms, including up to 70% of second-year residents. Among overlapping personal, professional, institutional, and lifestyle risk factors, barriers to accessing medical and mental health care are frequently cited as an important association in residents. Limited intervention studies suggest that providing basic needs, such as on-call meals, and facilitating physical wellness and social engagement among residents may result in sustained reductions in burnout. Urology residents continue to experience high rates of burnout and career choice regret among medical specialties. Evidence-based interventions and sustainable policies that address primary risk factors are urgently needed.

综述目的:泌尿外科住院医师的职业倦怠和职业选择后悔率较高,这可能会增加职业不满情绪、缩短职业寿命并加剧泌尿外科人才短缺。了解职业倦怠的发生率和风险因素有助于制定干预措施:多达 48% 的当代美国泌尿外科住院医师出现职业倦怠症状,其中包括多达 70% 的二年级住院医师。在重叠的个人、职业、机构和生活方式风险因素中,获得医疗和心理健康护理的障碍经常被认为与住院医师的职业倦怠有重要关联。有限的干预研究表明,提供基本需求(如随叫随到的膳食)以及促进住院医师的身体健康和社会参与可能会持续减少倦怠感。泌尿外科住院医师的职业倦怠率和职业选择后悔率在医学专科中一直居高不下。目前迫切需要针对主要风险因素的循证干预措施和可持续政策。
{"title":"Professional Burnout and Career Choice Regret in Urology Residents.","authors":"Kevin F Hanna, Kevin Koo","doi":"10.1007/s11934-024-01226-4","DOIUrl":"10.1007/s11934-024-01226-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>High rates of professional burnout and career choice regret among urology residents may increase professional dissatisfaction, shorten career longevity, and exacerbate urology workforce shortages. Understanding the prevalence of and risk factors for burnout may help develop interventions.</p><p><strong>Recent findings: </strong>Up to 48% of contemporary U.S. urology residents experience burnout symptoms, including up to 70% of second-year residents. Among overlapping personal, professional, institutional, and lifestyle risk factors, barriers to accessing medical and mental health care are frequently cited as an important association in residents. Limited intervention studies suggest that providing basic needs, such as on-call meals, and facilitating physical wellness and social engagement among residents may result in sustained reductions in burnout. Urology residents continue to experience high rates of burnout and career choice regret among medical specialties. Evidence-based interventions and sustainable policies that address primary risk factors are urgently needed.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"325-330"},"PeriodicalIF":2.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence as a Tool for Creating Patient Visit Summary: A Scoping Review and Guide to Implementation in an Erectile Dysfunction Clinic. 人工智能作为创建患者就诊摘要的工具:勃起功能障碍诊所的范围审查和实施指南。
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-11-18 DOI: 10.1007/s11934-024-01237-1
Supanut Lumbiganon, Elia Abou Chawareb, Muhammed A Moukhtar Hammad, Babak Azad, Dillan Shah, Faysal A Yafi

Purpose of review: In modern healthcare, the integration of artificial intelligence (AI) has revolutionized clinical practices, particularly in data management and patient visit summary creation. Manual creation of patient summary is repetitive, time-consuming, prone to errors, and increases clinicians' workload. AI, through voice recognition and Natural Language Processing (NLP), can automate this task more accurately and efficiently. Erectile dysfunction (ED) clinics, which deal with specific pattern of conditions together with an involvement of broader systemic issues, can greatly benefit from AI-driven patient summary. This scoping review examined the evidence on AI-generated patient summary and evaluated their implementation in ED clinics.

Recent findings: A total of 381 articles were initially identified, 11 studies were included for the analysis. These studies showcased various methodologies, such as AI-assisted clinical notes and NLP algorithms. Most studies have demonstrated the ability of AI to be used in real life clinical scenarios. Major electronic health record platforms are also integrating AI to their system. However, to date, no studies have specifically addressed AI for patient summary creation in ED clinics.

审查目的:在现代医疗保健领域,人工智能(AI)的整合给临床实践带来了革命性的变化,尤其是在数据管理和患者就诊摘要创建方面。人工创建病人就诊摘要重复、耗时、容易出错,而且增加了临床医生的工作量。人工智能通过语音识别和自然语言处理(NLP),可以更准确、更高效地自动完成这项任务。勃起功能障碍(ED)诊所在处理特定病症模式的同时,还涉及更广泛的系统性问题,因此人工智能驱动的患者摘要可使其受益匪浅。本范围综述研究了有关人工智能生成患者摘要的证据,并评估了其在 ED 诊所的实施情况:最初共确定了 381 篇文章,其中 11 项研究被纳入分析。这些研究展示了各种方法,如人工智能辅助临床笔记和 NLP 算法。大多数研究都证明了人工智能在实际临床场景中的应用能力。主要的电子病历平台也正在将人工智能集成到其系统中。然而,迄今为止,还没有研究专门针对在急诊室创建病人摘要的人工智能。
{"title":"Artificial Intelligence as a Tool for Creating Patient Visit Summary: A Scoping Review and Guide to Implementation in an Erectile Dysfunction Clinic.","authors":"Supanut Lumbiganon, Elia Abou Chawareb, Muhammed A Moukhtar Hammad, Babak Azad, Dillan Shah, Faysal A Yafi","doi":"10.1007/s11934-024-01237-1","DOIUrl":"10.1007/s11934-024-01237-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>In modern healthcare, the integration of artificial intelligence (AI) has revolutionized clinical practices, particularly in data management and patient visit summary creation. Manual creation of patient summary is repetitive, time-consuming, prone to errors, and increases clinicians' workload. AI, through voice recognition and Natural Language Processing (NLP), can automate this task more accurately and efficiently. Erectile dysfunction (ED) clinics, which deal with specific pattern of conditions together with an involvement of broader systemic issues, can greatly benefit from AI-driven patient summary. This scoping review examined the evidence on AI-generated patient summary and evaluated their implementation in ED clinics.</p><p><strong>Recent findings: </strong>A total of 381 articles were initially identified, 11 studies were included for the analysis. These studies showcased various methodologies, such as AI-assisted clinical notes and NLP algorithms. Most studies have demonstrated the ability of AI to be used in real life clinical scenarios. Major electronic health record platforms are also integrating AI to their system. However, to date, no studies have specifically addressed AI for patient summary creation in ED clinics.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"20"},"PeriodicalIF":2.5,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Post-RALP SUI and ED - What are and What Should we be Doing? RALP 术后 SUI 和 ED 的管理--我们正在做什么和应该做什么?
IF 2.5 2区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2024-11-15 DOI: 10.1007/s11934-024-01249-x
Thairo A Pereira, Jacob O Rust, Helen L Bernie

Purpose of review: Although there have been advancements in minimally invasive surgical techniques for radical prostatectomy, surgery can still significantly impact continence and erectile function (EF), resulting in considerable quality-of-life impairment. This review critically evaluates existing treatment options for male stress urinary incontinence (SUI) and erectile dysfunction (ED) post-robotic-assisted laparoscopic prostatectomy (RALP), alongside exploring emerging trends and discussing future directions for managing and preventing both conditions.

Recent findings: Patient history is pivotal in guiding surgical decisions, with the intensity of symptoms and their impact on the patient's life being primary influences for deciding the best treatment options for both SUI and ED. Penile rehabilitation strategies (PR) show promise in mitigating the effects of prostate cancer treatments on EF and improving overall health, though consensus is lacking on specific programs or initiation of timing for optimal recovery post-surgery. All patients undergoing RALP should receive preoperative counseling about SUI and early pelvic floor physical therapy. Fixed and adjustable slings effectively treat mild-to-moderate post-RALP SUI, while the artificial urinary sphincter is the gold standard for men with moderate or severe SUI. EF recovery after RALP faces obstacles such as patient characteristics, compliance, and cost, with no standardized PR approach. Future research should prioritize studies aiming to optimize treatment methods and enhance patient compliance.

综述目的:尽管根治性前列腺切除术的微创手术技术不断进步,但手术仍会严重影响尿失禁和勃起功能(EF),导致生活质量严重下降。这篇综述对机器人辅助腹腔镜前列腺切除术(RALP)术后男性压力性尿失禁(SUI)和勃起功能障碍(ED)的现有治疗方案进行了严格评估,同时探讨了新的趋势,并讨论了管理和预防这两种疾病的未来方向:患者病史在指导手术决策方面至关重要,症状的强度及其对患者生活的影响是决定 SUI 和 ED 最佳治疗方案的主要影响因素。阴茎康复策略(PR)在减轻前列腺癌治疗对EF的影响和改善整体健康方面大有可为,但对于手术后最佳康复的具体方案或启动时机还缺乏共识。所有接受前列腺癌根治术(RALP)的患者都应该在术前接受有关 SUI 的咨询,并尽早接受盆底物理治疗。固定式和可调式吊带可有效治疗 RALP 术后轻度至中度 SUI,而人工尿道括约肌是治疗中度或重度 SUI 男性的金标准。RALP 术后 EF 恢复面临着患者特征、依从性和成本等障碍,没有标准化的 PR 方法。未来的研究应优先考虑旨在优化治疗方法和提高患者依从性的研究。
{"title":"Management of Post-RALP SUI and ED - What are and What Should we be Doing?","authors":"Thairo A Pereira, Jacob O Rust, Helen L Bernie","doi":"10.1007/s11934-024-01249-x","DOIUrl":"10.1007/s11934-024-01249-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>Although there have been advancements in minimally invasive surgical techniques for radical prostatectomy, surgery can still significantly impact continence and erectile function (EF), resulting in considerable quality-of-life impairment. This review critically evaluates existing treatment options for male stress urinary incontinence (SUI) and erectile dysfunction (ED) post-robotic-assisted laparoscopic prostatectomy (RALP), alongside exploring emerging trends and discussing future directions for managing and preventing both conditions.</p><p><strong>Recent findings: </strong>Patient history is pivotal in guiding surgical decisions, with the intensity of symptoms and their impact on the patient's life being primary influences for deciding the best treatment options for both SUI and ED. Penile rehabilitation strategies (PR) show promise in mitigating the effects of prostate cancer treatments on EF and improving overall health, though consensus is lacking on specific programs or initiation of timing for optimal recovery post-surgery. All patients undergoing RALP should receive preoperative counseling about SUI and early pelvic floor physical therapy. Fixed and adjustable slings effectively treat mild-to-moderate post-RALP SUI, while the artificial urinary sphincter is the gold standard for men with moderate or severe SUI. EF recovery after RALP faces obstacles such as patient characteristics, compliance, and cost, with no standardized PR approach. Future research should prioritize studies aiming to optimize treatment methods and enhance patient compliance.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"19"},"PeriodicalIF":2.5,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Urology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1